Conversing with Professor Antoine Italiano, a worldwide expert on early drug development, phase I oncology trials and immuno-oncology, upon the release of a recent article in Clinical Cancer Research.
T cells, macrophages, NKs, dendritic cells, mast cells..., the entire Explicyte team is proud to wear white and even show up in our preferred white cells warriors - fighting together to beat back cancer!
As experts in immuno-oncology, we at Explicyte are fully committed to making cancer immunotherapy a standard of care known to as many people as possible.
We are thrilled to announce that Explicyte will be attending the AACR annual meeting this year in Orlando, to share our latest developments and translational research works.